These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 18363533)

  • 1. Effectiveness of probiotics in the treatment of irritable bowel syndrome.
    Wilhelm SM; Brubaker CM; Varcak EA; Kale-Pradhan PB
    Pharmacotherapy; 2008 Apr; 28(4):496-505. PubMed ID: 18363533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review article: probiotics and prebiotics in irritable bowel syndrome.
    Spiller R
    Aliment Pharmacol Ther; 2008 Aug; 28(4):385-96. PubMed ID: 18532993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
    Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
    Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescript-Assist probiotic-prebiotic treatment for irritable bowel syndrome: a methodologically oriented, 2-week, randomized, placebo-controlled, double-blind clinical study.
    Bittner AC; Croffut RM; Stranahan MC
    Clin Ther; 2005 Jun; 27(6):755-61. PubMed ID: 16117982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
    Rahimi R; Nikfar S; Abdollahi M
    Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating.
    Kim HJ; Vazquez Roque MI; Camilleri M; Stephens D; Burton DD; Baxter K; Thomforde G; Zinsmeister AR
    Neurogastroenterol Motil; 2005 Oct; 17(5):687-96. PubMed ID: 16185307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irritable bowel syndrome: a mild disorder; purely symptomatic treatment.
    Prescrire Int; 2009 Apr; 18(100):75-9. PubMed ID: 19585728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized controlled treatment trial of irritable bowel syndrome with a probiotic E.-coli preparation (DSM17252) compared to placebo.
    Enck P; Zimmermann K; Menke G; Klosterhalfen S
    Z Gastroenterol; 2009 Feb; 47(2):209-14. PubMed ID: 19197823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use.
    Barbara G; Stanghellini V; Cremon C; De Giorgio R; Gargano L; Cogliandro R; Pallotti F; Corinaldesi R
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S214-7. PubMed ID: 18685517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacillus coagulans significantly improved abdominal pain and bloating in patients with IBS.
    Hun L
    Postgrad Med; 2009 Mar; 121(2):119-24. PubMed ID: 19332970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing irritable bowel syndrome without special drugs. Another IBS drug has been taken off the market because of serious side effects. Now what?
    Harv Womens Health Watch; 2007 Jun; 14(10):3-4. PubMed ID: 18018315
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical studies on alleviating the symptoms of irritable bowel syndrome.
    Kajander K; Korpela R
    Asia Pac J Clin Nutr; 2006; 15(4):576-80. PubMed ID: 17077079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis.
    Didari T; Mozaffari S; Nikfar S; Abdollahi M
    World J Gastroenterol; 2015 Mar; 21(10):3072-84. PubMed ID: 25780308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention.
    Kajander K; Hatakka K; Poussa T; Färkkilä M; Korpela R
    Aliment Pharmacol Ther; 2005 Sep; 22(5):387-94. PubMed ID: 16128676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mixture of Escherichia coli (DSM 17252) and Enterococcus faecalis (DSM 16440) for treatment of the irritable bowel syndrome--a randomized controlled trial with primary care physicians.
    Enck P; Zimmermann K; Menke G; Müller-Lissner S; Martens U; Klosterhalfen S
    Neurogastroenterol Motil; 2008 Oct; 20(10):1103-9. PubMed ID: 18565142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rationale and clinical effectiveness of probiotics in irritable bowel syndrome.
    Ringel Y; Ringel-Kulka T
    J Clin Gastroenterol; 2011 Nov; 45 Suppl():S145-8. PubMed ID: 21992954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of tegaserod on colonic transit time in male patients with constipation-predominant irritable bowel syndrome.
    Harish K; Hazeena K; Thomas V; Kumar S; Jose T; Narayanan P
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1183-9. PubMed ID: 17688659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit.
    Houghton LA; Lea R; Agrawal A; Reilly B; Whorwell PJ
    Gastroenterology; 2006 Oct; 131(4):1003-10. PubMed ID: 17030170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The spectrum of irritable bowel syndrome: A clinical review.
    Gilkin RJ
    Clin Ther; 2005 Nov; 27(11):1696-709. PubMed ID: 16368443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of irritable bowel syndrome. A case control experience.
    Astegiano M; Pellicano R; Terzi E; Simondi D; Rizzetto M
    Minerva Gastroenterol Dietol; 2006 Dec; 52(4):359-63. PubMed ID: 17108865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.